![]() |
![]() |
There has been in the last 3 years numerous changes and additions to the healthful website as JK realized the extent of corruption worked by pharma on the evidence base. Major revision in causes of heart disease.
Two Changes in content coming up
For confirmation from journal articles on primary role of infective agent enter into http://scholar.google.com/ terms such as bacteria + atherosclerosis or go to http://healthfully.org/rl/id8.html and id9 for collection of articles
For confirmation of cholesterol myth enter into http://scholar.google.com/ or http://www.amazon.com/ cholesterol myth, or go to http://healthfully.org/rl/id5.html for collection of journal articles.
The article below was done in 2009, before JK discovered the extent of the corruption worked by pharma. Much of what has been stated here was based upon a reliance of pharma’s opinion leaders. The recommended section of this website has a far better analysis—see http://healthfully.org/rc/
PhARMA has created an overly simplified and
fundamentally incorrect picture of cardiovascular disease, which of course
promotes sales of their most profitable family of drugs of all times,
statins. Understanding the process will
help you understand in-part why statins fail to prevent CVD better than a
placebo, and why the only long term study of niacin (6-years) lowered mortality
by only 11%. Using a surrogate marker of
cholesterol level is misleading; the reasons are contained in the two
explanations below. Important
points: It isn’t cholesterol
that causes cardiovascular disease (CDV),
but rather oxidative damage to low-density lipoproteins (LDL). LDL is the blood
transport system for cholesterol, which isn’t blood soluble. Cholesterol
is vital for all cells. LDL is water (blood) soluble
complexes, and house approximately 1,500 cholesterol molecules. When damage
by a reactive chemical, LDL elicits
a response from a particular type of white-blood cell that start the process of
forming plaque. Over a lifetime the
plaque accumulates and develops into cardiovascular disease (CDV). Once developed, the most one
can do is try to slow its progression and allow the body to slowly harden
plaque into a stable form. Soft plaque
that leaks causes most of the strokes and heart attacks. Thus cholesterol
and LDL levels are
moderately associated with CDV. The
more LDL and the more reactive chemicals
(such as carbon monoxide from cigarettes) over a lifetime, the great is the
extent of CDV. PhARMA wants doctors
and patients to believe
that statin family of drugs because they lower cholesterol that they can make a
big different—that’s B.S. For well illustrated
and easily understood explanation of
the atherogenesis process, go to http://healthfully.org/heart/id5.html. JK. Similar statement
from a journal article:
Atherosclerosis develops over the course of 50 years, beginning in the
early teenage years. The causes of this process appear to be lipid retention,
oxidation, and modification, which provoke chronic inflammation at susceptible
sites in the walls of all major conduit arteries. Initial fatty streaks evolve
into fibrous plaques, some of which develop into forms that are vulnerable to
rupture, causing thrombosis or stenosis. Erosion of the surfaces of some
plaques and rupture of a plaque’s calcific nodule into the artery lumen also may
trigger thrombosis. The process of plaque development is the same regardless of
race/ethnicity, sex, or geographic location, apparently worldwide. However, the
rate of development is faster in patients with risk factors such as
hypertension, tobacco smoking, diabetes mellitus, obesity, and genetic
predisposition. At ftp://82.239.144.183/bibli/-%20Revue%20Articles%20FB/Biblio%20090410/110.0901-Pathology%20of%20AthS,%20Plaque%20development%20and%20plaque%20responses%20to%20medical%20treatment%20(Insull,%20Am%20J%20Med).pdf |
![]() |
|
![]() |
![]() |
![]() |
Enter supporting content here Those who have a financial interest in the outcome manipulate the results, Major study finds that all 37 journal articles positive effects over stated; the average was 32%. Statins cause erectile dysfunction, cognitive imparement, and cancer. Lipitor (2011) lifetime sales $131
billion, tops all drugs. Plavix at
$60 billion is second.
STATINS CANCER Link 52% short term LA Times, Health section, Vytorin, the
combination drug (simvastatin (better known by its commercial name Zocor) and ezetimibe--known as Zetia) prescribed to lower
cholesterol, sustained another blow today, when the author of a major clinical trial announced that the medication had failed
to drive down hospitalization and death due to heart failure in patients with narrowing of the aortic valve. In the process,
researchers in Today's findings
suggested something more ominous: the incidence of cancer -- and of dying of cancer -- was significantly higher in the patients
taking Vytorin. Altogether, 67 patients on placebo developed cancer during the trial.
Among subjects on Vytorin, 102 developed cancers of various kinds.* This
is the second adverse press—the first being in March 08, when the ENHANCE trial found that Vytorin fared no better than
a placebo at reducing plaque buildup on the walls of patients' arteries.* * Comments by jk Simvastatin (Zocor) is off patent. Thus in a scramble for profits a combination drug (on patent) was introduced. Direct to consumer market cost $155 in 07—mainly TV ads. * The pressing issue is that since the development of Statins, the very first animal studies in the 60s it has been known that Statins increase the incidents of cancer. However, nearly all studies done thereafter have not included cancer. *
Several studies have failed to find a reduction in the build of plaque, even thought the statins including Zocor, reduce
EXTENDED RELEASE NIACIN IS A SAFER, AND A MORE EFFECTIVE WAY TO LOWER MI RISK! |